|
REPL
|
Replimune Group, Inc.
|
0.12%
|
US
|
NASDAQ
|
|
MNKD
|
MannKind Corporation
|
0.12%
|
US
|
NASDAQ
|
|
KROS
|
Keros Therapeutics, Inc.
|
0.12%
|
US
|
NASDAQ
|
|
CINC
|
CinCor Pharma, Inc.
|
0.12%
|
US
|
NASDAQ
|
|
ADPT
|
Adaptive Biotechnologies Corporation
|
0.12%
|
US
|
NASDAQ
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
0.11%
|
US
|
NASDAQ
|
|
GERN
|
Geron Corporation
|
0.11%
|
US
|
NASDAQ
|
|
BBIO
|
BridgeBio Pharma, Inc.
|
0.11%
|
US
|
NASDAQ
|
|
ZNTL
|
Zentalis Pharmaceuticals, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
QURE
|
uniQure N.V.
|
0.10%
|
US
|
NASDAQ
|
|
MORF
|
Morphic Holding, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
GRFS
|
Grifols, S.A.
|
0.10%
|
US
|
NASDAQ
|
|
ACRS
|
Aclaris Therapeutics, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
RNA
|
Avidity Biosciences, Inc.
|
0.10%
|
US
|
NASDAQ
|
|
RGNX
|
REGENXBIO Inc.
|
0.09%
|
US
|
NASDAQ
|
|
PLRX
|
Pliant Therapeutics, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
NVAX
|
Novavax, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
INVA
|
Innoviva, Inc.
|
0.09%
|
US
|
NASDAQ
|
|
INBX
|
Inhibrx, Inc.
|
0.09%
|
US
|
NASDAQ
|